PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Wall Street
Price Targets

PPGN Price Targets Summary
PolyPeptide Group AG

Wall Street analysts forecast PPGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPGN is 32.64 CHF with a low forecast of 19.19 CHF and a high forecast of 47.25 CHF.

Lowest
Price Target
19.19 CHF
31% Downside
Average
Price Target
32.64 CHF
17% Upside
Highest
Price Target
47.25 CHF
69% Upside
PolyPeptide Group AG Competitors:
Price Targets
300759
Pharmaron Beijing Co Ltd
6% Upside
CGEN
Compugen Ltd
262% Upside
STVN
Stevanato Group SpA
39% Upside
GENO
Genovis AB
42% Upside
RVTY
Revvity Inc
27% Upside
QTRX
Quanterix Corp
76% Upside
CDXS
Codexis Inc
52% Upside
IQV
IQVIA Holdings Inc
27% Upside

Revenue
Forecast

Revenue Estimate
PolyPeptide Group AG

For the last 4 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 14%.

12%
Past Growth
14%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PPGN's stock price target?
Price Target
32.64 CHF

According to Wall Street analysts, the average 1-year price target for PPGN is 32.64 CHF with a low forecast of 19.19 CHF and a high forecast of 47.25 CHF.

What is PolyPeptide Group AG's Revenue forecast?
Projected CAGR
14%

For the last 4 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 14%.

Back to Top